SI BELLE / FORMULATION PROFILEHydraNoor
HA-focused profile
View individual profile →PLLA + HA + mannitol profile
The supplied PLLA+ 380 box separately declares poly-L-lactic acid, two HA fractions and mannitol. It is not treated as the same formulation as PLLA+ 400.

The supplied PLLA+ 380 box separately declares poly-L-lactic acid, two HA fractions and mannitol. It is not treated as the same formulation as PLLA+ 400.
380 mg × 1 vial — pack declaration
| Field | Source-supported information |
|---|---|
| Poly-L-lactic acid | 200 mg — pack declaration |
| H-HA + L-HA | 40 mg + 40 mg — pack declaration |
| Mannitol | 100 mg — pack declaration |
| Total labelled content | 380 mg × 1 vial |
| Pack wording | FUNCTION: Facial Serum; For external use only; For professional use only |
Full formulation, intended use, storage, shelf life and market status should be checked against the current model-specific documents before supply. No treatment instructions or outcomes are inferred from the product name.
Professional enquiries only. These summaries do not replace a current IFU, clinical judgement or market-specific documentation. Requests open an email draft; nothing is submitted automatically.
Product information · Technical documentation · Partnership discussions